IGFBP2 and myeloid sarcoma: Inconsistent with these results, [15, 32] reported no significant association between MS patients and the healthy group regarding CSF levels of IGFBP-2, however, a significant correlation between CSF IGFBP-2 levels and the age of individuals in the control group was revealed by Pirttilä et al. [32] study.